Palmer Pamela P 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Palmer Pamela P
DirectorChief Medical Officer
Transactions
- Tax Payment
Common Stock
2022-02-11$0.40/sh−7,927$3,182→ 777,184 total - Award
Common Stock
2022-02-11+122,500→ 785,111 total - Award
Stock Option (Right to Buy)
2022-02-11+245,000→ 245,000 totalExercise: $0.40Exp: 2032-02-11→ Common Stock (245,000 underlying)
Footnotes (4)
- [F1]The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F4]On February 11, 2022, the reporting person was granted an option to purchase 245,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.